Sutro Biopharma Cash from Investing (TTM) Analysis

Sutro Biopharma Inc (STRO)

3.83 -0.11 (-2.79%) USD | NASDAQ | May 03, 16:00

3.84 +0.01 (+0.26%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	-3.924M
September 30, 2023	-18.29M
June 30, 2023	17.69M
March 31, 2023	-0.553M
December 31, 2022	-35.02M
September 30, 2022	23.64M
June 30, 2022	99.44M
March 31, 2022	57.40M
December 31, 2021	-97.32M
September 30, 2021	-102.29M
June 30, 2021	-99.75M

Date	Value
March 31, 2021	-162.76M
December 31, 2020	0.604M
September 30, 2020	-7.261M
June 30, 2020	2.255M
March 31, 2020	68.58M
December 31, 2019	-51.13M
September 30, 2019	-57.05M
June 30, 2019	-148.68M
March 31, 2019	-157.90M
December 31, 2018	-80.19M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-162.76M

Minimum

Mar 2021

99.44M

Maximum

Jun 2022

-27.07M

Average

-7.261M

Median

Sep 2020

Cash from Investing (TTM) Benchmarks